Endocrinology

Probiotic supplementation using a mix of three Lactobacillus strains naturally occurring in the human gut microbiota protects against lumbar spine bone loss in healthy, early postmenopausal women, say researchers recently writing in The Lancet Rheumatology.

An oral tablet combining empagliflozin, linagliptin, metformin hydrochloride will soon be available on US markets.

A new analysis of more than 125,000 found no differences in mortality or MACE based on type of insulin used.

The GLP-1 agonist now has indications for the reduction of MACE and the management of A1C in patients with type 2 diabetes.

A recent analysis of participants in the NHANES database found low fat and Mediterranean diets were linked to lower serum testosterone levels in men.

A 38-year-old woman went to the doctor with several complaints that seemed unrelated but they had started within the last few months. She was feeling depressed and fatigued with tingling and numbness in her hands and feet. Can you diagnose this patient?

Novo Nordisk announced the US FDA's approval of insulin aspart injection 100 u/mL (Fiasp) for glycemic control in children in a press release on Monday morning.

A recent study from the Mayo Clinic of Rochester, MN is suggested diabetes mellitus is an independent risk factor for the development of heart failure.

A look back at the developments and interviews that caught the most attention this year.

How women who undergo menopause before age 40 may be at a greater risk of heart disease.

A meta-analysis of more than 1 million patients and 2 dozen studies has revealed patients over 60 with hypothyroidism were at a 26% greater chance of all-cause mortality.

How technology, innovation, and preventive care drove the last 10 years of improved public heart health.

An analysis of more than 4 million patients in the Swedish Birth Registry is shining light on the associations between preterm birth and the development of diabetes as a child or young adult.

Discussing why initiatives and policy changes in the fight against obesity and diabetes have been perceived as less successful than those against smoking and educating on cardiovascular diseases.

A mother brought her 7-year-old boy to the eye doctor after he complained for several months about increasing photophobia during outdoor activities like soccer practice and playground outings. She also noticed that he had been thirstier than usual during his soccer games, but wasn’t sweating as much as he usually did. During the slit lamp exam, the doctor noted crystals throughout his cornea and conjunctiva. What's your diagnosis?

Postmenopausal women who participate in vigorous physical activity have a lower risk of total and hip fractures, but higher knee fracture risk, say researchers recently writing in JAMA Network Open.

Toujeo has been given an added indication which allows its use for blood sugar control in patients as young as 6 years old.

In this slideshow, we review 10 new drugs or new indications for diabetes and other endocrine conditions.

Investigators examine how different supplementation impacts kidney function in patients with type 2 diabetes.

A JAMA study finds that treating elderly patients who have subclinical hypothyroidism does not improve hypothyroid symptoms or fatigue.

A literature review published in JAMA Internal Medicine finds that many medical tests are overused and overtreatment is common and potentially harmful.

In this month's "Endocrine Feedback" column, Dr. Melissa Young explores how her career has evolved over the years and questions what the future may hold.

During AHA, investigators suggest ways to improve care for women in regard to diabetic and cardiovascular interventions.

Investigators present data from the CREDENCE trial during AHA.

New empagliflozin data assesses the SGLT-2 inhibitor versus GLP-1 agonists and DPP-4 inhibitors for patients with heart failure.

The adult heart failure study is the first of its kind: a completely decentralized, indication-seeking clinical trial.

George Bakris, MD, discusses how nephrologists can work with other specialists and what the highlight of Kidney Week was.

George Bakris, MD, discusses the major study during Kidney Week, as well as what diseases should get more attention in future research.

Matthew Weir, MD talks about some of the challenges in nephrology and what has people buzzing while at Kidney Week.

During Kidney Week, investigators present data showing that canagliflozin could be beneficial for patients across various levels of kidney function.